Shareholding disclosure

Basilea Pharmaceutica AG

Declared position

19.964%

Threshold

Crossed downwards

Timeline

Published

25.05.2013

Transaction

21.05.2013

Voting rights breakdown

Voting rights acquired0%

Voting rights sold19.964%

Below threshold0%

Notice details

CategorySingle shareholder

ExchangeXSWX

Notification ID

TAD5M00045

Beneficial owner

Basilea Pharmaceutica AG

Declared address

Basilea Pharmaceutica AG, 4005 Basel

Ausübung von Mitarbeiteroptionen gemäss Optionsplan, welche zum Erwerb von Namenaktien der Basilea Pharmaceutica AG (Basiswert, Bezugsverhältnis 1:1) oder entsprechendem Cash Settlement berechtigen.

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

Basilea Pharmaceutica AG

Basilea Pharmaceutica AG, Allschwil25.05.2013TAD5M00045

Disclosure summary

Basilea Pharmaceutica AG disclosed a holding in Basilea Pharmaceutica AG, Allschwil on the disposal side, published by SIX Exchange Regulation on 25.05.2013, at 19.964% of voting rights. Notice category: Single shareholder.

Disclosed position

19.964%

Voting rights sold

Voting rights acquired0%

Voting rights sold19.964%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

Basilea Pharmaceutica AG disclosed a holding in Basilea Pharmaceutica AG, Allschwil, published on 25.05.2013.

Publication date25.05.2013

Transaction date21.05.2013

Issuing companyBasilea Pharmaceutica AG, Allschwil

Beneficial ownerBasilea Pharmaceutica AG

Declared addressBasilea Pharmaceutica AG, 4005 Basel

CategorySingle shareholder

Voting rights acquired0%

Voting rights sold19.964%

Below threshold0%

ExchangeXSWX

Notification IDTAD5M00045

Commercial register

CHE-101.175.068

Registered

Zefix record

Conditions

Ausübung von Mitarbeiteroptionen gemäss Optionsplan, welche zum Erwerb von Namenaktien der Basilea Pharmaceutica AG (Basiswert, Bezugsverhältnis 1:1) oder entsprechendem Cash Settlement berechtigen.

Source: SIX Exchange Regulation · Publication date: 25.05.2013

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open